CytomX Therapeutics, Inc. (CTMX)

4.82 -0.07 (-1.43%) USD  |  NASDAQ  |  Apr 17, 16:00
4.86 +0.04 (+0.83%) After-Hours: 20:00
More

CytomX Therapeutics Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for CTMX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Catalyst Pharmaceuticals, Inc. Upgrade
Rigel Pharmaceuticals, Inc. Upgrade
REGENXBIO, Inc. Upgrade
Ovid Therapeutics, Inc. Upgrade
Olema Pharmaceuticals, Inc. --